Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Etoricoxib/Tramadol FDC vs Individual Components
NCT05533073Phase 1Completed
- Sponsor
- Laboratorios Silanes
- Start
- Aug 2020
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial in pain comparing Etoricoxib/Tramadol FDC, Etoricoxib and Tramadol (3 arms). Primary endpoints: Maximum observed concentration, Area under the curve from time zero to the last measurable concentration and 4 more. Started Aug 2020; status: completed.
02
Drugs
etoricoxibtramadol
03
Conditions
pain
Beyond the preview
Go deeper on NCT05533073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05533073.